カテゴリ： GlobalData, アメリカ, 企業調査

Mayo Clinic-製薬・医療分野：企業M&A・提携分析

◆英語タイトル：Mayo Clinic - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード：DATA8013215
◆発行会社（調査会社）：GlobalData
◆発行日：2017年11月28日
◆ページ数：72
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in most of the major disease categories and health disorders. It conducts active human research studies and new human research studies approved by institutional review at its facilities. Mayo also operates several colleges of medicine which offers various residency and fellowship programs. Mayo’s other major facilities include Mayo Arizona, Mayo Minnesota, and Mayo Clinic Health System, a network of clinics and hospitals in several states. Mayo is headquartered in Jacksonville, Florida, the US.

Mayo Clinic – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Clinic, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Mayo Clinic, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Qrativ Raises USD8.3 Million in Series A Financing 13
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 15
DayTwo Raises USD12 Million in Series A Financing 16
Second Genome Raises USD42.6 Million in Series B Financing 17
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
Partnerships 21
Mayo Clinic and nference Form Joint Venture 21
Baxter International and Mayo Clinic Enter into Research Agreement 22
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Licensing Agreements 28
Evelo Biosciences Enters into Licensing Agreement with Mayo Clinic 28
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 30
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 31
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 32
Mayo Clinic – Key Competitors 33
Mayo Clinic – Key Employees 34
Mayo Clinic – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Jul 14, 2017: Mayo Clinic, nference Launch a Startup to Discover, Develop Treatments for Diseases with Unmet Medical Need 37
Research And Development 39
Dec 13, 2016: Tyme Technologies Announces Launch of a Pancreatic Research Program with the Mayo Clinic Led by Dr. Martin Fernandez-Zapico 39
Legal and Regulatory 40
Jul 27, 2016: Updated Testing Guidelines Make More Women Eligible for Herceptin, yet Benefit Uncertain 40
Government and Public Interest 41
Nov 01, 2017: New Study Links Severe Hot Flashes With Greater Risk of Obstructive Sleep Apnea 41
Oct 24, 2017: Proton therapy may be better option for elderly patients with esophageal cancer 42
Sep 25, 2017: Halving radiation therapy for HPV-related throat cancer offers fewer side effects, similar outcomes 43
Sep 18, 2017: Scientists Discover Novel Mechanism Underlying ALS and Related Dementia 44
Aug 29, 2017: Study finds hormone therapy improves sleep quality for recently menopausal women 45
Aug 25, 2017: Study identifies genes linked to better immune response to flu vaccine 46
May 02, 2017: Mayo Clinic researchers develop new tumor-shrinking nanoparticle to fight cancer, prevent recurrence 47
Jan 09, 2017: Mayo Clinic researchers identify new potential treatment for cancer metastasis 48
Sep 15, 2016: Mayo receives federal grant to test innovative triple-negative breast cancer vaccine 49
Jul 27, 2016: Gene therapy for metabolic liver diseases shows promise in pigs 50
Jul 25, 2016: Scientists Test Ways to Discuss Opioid Risks With ER Patients 51
Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 52
Jun 14, 2016: Mayo Clinic researchers develop accurate way to measure growth factor linked to aging 54
May 05, 2016: Protein may Predict Response to Immunotherapy in Patients with Metastatic Melanoma 55
May 04, 2016: $7 Million Research Funding Award for Migraine Research 56
Apr 01, 2016: TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma treatment 57
Mar 29, 2016: Researchers investigate four promising new treatments for Lyme disease 58
Mar 04, 2016: Reducing Variability in Spirometry Testing for Clinical Trials, New Webinar Hosted by Xtalks 60
Feb 18, 2016: Surgery and stenting safe, effective lowering long-term risk of stroke 61
Feb 11, 2016: Long-term benefits of ‘senolytic’ drugs on vascular health in mice 62
Feb 08, 2016: New Lyme-disease-causing bacteria species discovered 63
Product News 65
Nov 20, 2017: New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows 65
Nov 16, 2016: Next-generation biomaterial being developed to treat bleeding 67
Nov 01, 2017: Mayo Clinic researchers find genetic pathways to individualized treatment for advanced prostate cancer 68
Aug 22, 2016: Mayo Clinic researchers investigate protein’s role in cell division 69
May 03, 2017: Mayo Clinic-invented technologies show brain tumor firmness, adhesion before surgery 70
Jan 04, 2016: Mayo Clinic researchers reduce stem cell dysfunction and metabolic disease in aged mice 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Tables
Mayo Clinic, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Mayo Clinic, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Mayo Clinic, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Mayo Clinic, Deals By Therapy Area, 2011 to YTD 2017 9
Mayo Clinic, Medical Devices Deals, 2011 to YTD 2017 10
Mayo Clinic, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Qrativ Raises USD8.3 Million in Series A Financing 13
Evelo Biosciences Raises USD50 Million in Series B Financing 14
DayTwo Secures USD12 Million in Series A Funding 15
DayTwo Raises USD12 Million in Series A Financing 16
Second Genome Raises USD42.6 Million in Series B Financing 17
Unity Biotechnology Raises Funds in Venture Financing 19
AssureRx Health Raises Additional USD15 Million in Series D Financing 20
Mayo Clinic and nference Form Joint Venture 21
Baxter International and Mayo Clinic Enter into Research Agreement 22
Evelo Biosciences Enters into Research Agreement with Mayo Clinic 23
EnBiotix Partners with Mayo Clinic 24
Inovio Pharma Partners with National Cancer Institute and Mayo Clinic 25
GE Ventures Forms Joint Venture with Mayo Clinic 26
Morphotek Enters into Agreement with Mayo Clinic 27
Evelo Biosciences Enters into Licensing Agreement with Mayo Clinic 28
Mayo Clinic Enters into Licensing Agreement with ID Pharma 29
TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology 30
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 31
Zumbro Discovery Enters into Licensing Agreement with Mayo Clinic 32
Mayo Clinic, Key Competitors 33
Mayo Clinic, Key Employees 34
Mayo Clinic, Other Locations 35
Mayo Clinic, Subsidiaries 35
Mayo Clinic, Joint Venture 36

★海外企業調査レポート[Mayo Clinic-製薬・医療分野：企業M&A・提携分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Housing Development Finance Corporation Ltd：企業の戦略・SWOT・財務情報
    Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Housing Development Finance Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Soligenix Inc (SNGX)：製薬・医療：M&Aディール及び事業提携情報
    Summary Soligenix Inc (Soligenix) is a late-stage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures. It develops biotherapeutics for the treatment of orphan diseases such as cutaneous T-cell lymph …
  • Genedata AG：医療機器：M&Aディール及び事業提携情報
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Delta Corporation Limited：企業の戦略・SWOT・財務情報
    Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Delta Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Oki Electric Industry Co., Ltd. (6703)：企業の財務・戦略的SWOT分析
    Oki Electric Industry Co., Ltd. (6703) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Koninklijke Vopak NV (VPK)：企業の財務・戦略的SWOT分析
    Koninklijke Vopak NV (VPK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Valecha Engineering Ltd：企業の戦略・SWOT・財務情報
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Viridian Group Investments Ltd：企業の戦略的SWOT分析
    Viridian Group Investments Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Merck KGaA (MRK)：製薬・医療：M&Aディール及び事業提携情報
    Summary Merck KGaA (Merck), a subsidiary of E. Merck KG, is a pharmaceutical and chemical company. It discovers, develops and manufactures prescription drugs to treat cancer, multiple sclerosis, and infertility and over-the-counter products for colds and pain; and develops liquid crystal mixtures, O …
  • Saudi Airlines Catering：企業の戦略・SWOT・財務分析
    Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report Summary Saudi Airlines Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • bioMerieux Inc-医療機器分野：企業M&A・提携分析
    Summary bioMerieux Inc (bioMerieux), a subsidiary of Institut Merieux SA is a provider of diagnostic solutions. The company offers its products for clinical solutions which include blood culture, cancer diagnostics, cardiovascular disease, cardiovascular pathology, clinical laboratories, companion d …
  • Enstar Group Ltd.：企業のM&A・事業提携・投資動向
    Enstar Group Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Enstar Group Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Activision Blizzard, Inc.：企業の戦略・SWOT・財務分析
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Alcoa Inc：戦略・SWOT・企業財務分析
    Alcoa Inc - Strategy, SWOT and Corporate Finance Report Summary Alcoa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • FTI Consulting, Inc.：企業の戦略・SWOT・財務情報
    FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report Summary FTI Consulting, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Acorda Therapeutics Inc (ACOR)：企業の財務・戦略的SWOT分析
    Acorda Therapeutics Inc (ACOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mocon Inc (MOCO)：企業の財務・戦略的SWOT分析
    Summary Mocon Inc (Mocon), a subsidiary of AMETEK Inc, is a construction equipment manufacturing company that offers measuring instruments. The company provides permeation testing instruments, microbial detection products, package testing instruments, and physical testing instruments. It offers cons …
  • Altium Ltd：企業の戦略・SWOT・財務情報
    Altium Ltd - Strategy, SWOT and Corporate Finance Report Summary Altium Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • SEAKR Engineering, Inc.：企業の戦略・SWOT・財務分析
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • ProPhotonix Limited (STKR)：企業の財務・戦略的SWOT分析
    ProPhotonix Limited (STKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆